Status:
COMPLETED
The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Fatty Liver
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This randomized double blind clinical trial was performed in patients with non-alcoholic fatty liver disease.They were randomly assigned to lifestyle modification alone or lifestyle modification plus ...
Detailed Description
This randomized double blind clinical trial was performed in patients with the evidence of fatty liver in ultrasonography. After excluding other causes, participants with persistent elevated serum ami...
Eligibility Criteria
Inclusion
- Patients with persistent elevated aminotransferase levels and the evidence of fatty liver in ultrasonography, who were referred to a gastroenterology clinic.
Exclusion
- alcohol use (more than 20 gram per day in men and 10 gram per day in women per day),
- heart disease (ischemic or congestive),
- hepatic disease (viral hepatitis, autoimmune hepatitis, wilson disease, hemochromatosis, liver mass lesion),
- renal disease (serum creatinine concentration of \> 1.5 mg/dl),
- any severe systemic co-morbidities, neoplasm,
- using any hepatotoxic medication during the past 3 months,
- pregnant or lactating women.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02283710
Start Date
May 1 2013
End Date
May 1 2014
Last Update
November 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastroenterology clinic, Sina Hospital
Tehran, Tehran Province, Iran